11 Industrials Stocks Moving In Monday’s After-Market Session
Gainers Vertical Aerospace (NYSE:EVTL) stock moved upwards by 10.2% to $1.62 during Monday’s after-market session. The market value…
Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.
Why Desktop Metal Shares Are Soaring Today
Desktop Metal (NYSE: DM) shares are trading higher after the company reported better-than-expected fourth-quarter sales results.
Dow Jumps Over 300 Points; Best Buy Profit Beats Views
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Thursday.
The Dow traded up 0.97% to 32,978.95 while the NASDAQ rose 0.59% to 11,446.55. The S&P 500 also rose, gaining, 0.61% to 3,975.37.
Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Exela Technologies, Inc. (NASDAQ: XELA) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million and other related transactions.
Benzinga Pro’s Top 5 Stocks To Watch For Thursday, March 2, 2023: TSLA, AMD, CRWD, DM, USAU
Tesla (TSLA) - Shares were down 8% Thursday morning following the company's Investor Day event Wednesday afternoon. Tune into Benzinga's Stocks To Watch podcast around market open on
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell
• Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023
Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics…
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.
